Integra Lifesciences Holdings
S&P 600
$15.50
-0.26%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Moderate debt: debt-to-equity of 0.7.
- Current assets comfortably cover current liabilities (current ratio 2.54).
!Watch-points
- Thin interest cover: operating profit covers interest only about -5.7 times.
- Return on equity is on the lower side at -49.5%.
- Return on capital employed is on the lower side at -15.9%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
0.68
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Piotroski F-ScoreModerate
4 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$1.21B
Current Price$ 15.50
High / Low$ 20.49 / 8.70
Stock P/E-2.30
Book Value$ 13.35
Dividend Yield0%
ROCE-15.88%
ROE-49.50%
Debt to Equity0.70
Current Ratio2.54
P/B Ratio1.155423
EPS$ -6.74
Debt$726.56M
PAT Margin-31.58%
Cash PAT$-471.67M
ICR-5.72